INSIGHTS ON QUALITY CONTROL
-
![Lessons Learned From FDA 483s And Warning Letters – Strengthening GMP Cleanroom Compliance In Life Sciences]( "Lessons From FDA 483s And Warning Letters: Cleanroom Compliance")
Lessons From FDA 483s And Warning Letters: Cleanroom ComplianceLearn critical lessons from FDA 483 observations and Warning Letters to proactively address common GMP cleanroom compliance failures and build an inspection-ready facility.
-
![cGMP vs GMP]( "cGMP Vs GMP In Cleanrooms: Understanding The Differences That Matter")
cGMP Vs GMP In Cleanrooms: Understanding The Differences That MatterDifferentiating GMP from cGMP helps facility teams design cleanrooms that meet modern contamination controls, process flows, and regulatory standards.
-
![GettyImages-2002525379-production-solid-dose-capsules]( "High Precision Mass Inspection With Accuracy Of ±0.5 mg Achieved")
High Precision Mass Inspection With Accuracy Of ±0.5 mg AchievedExplore how advances in capsule checkweighing technology enable more precise mass inspection, helping improve quality control, reduce variability, and meet increasingly stringent production requirements.
-
![Cleanroom GettyImages-184293451]( "The Pain Of Change – Could Suppliers Be Part Of The Cure?")
The Pain Of Change – Could Suppliers Be Part Of The Cure?Change is a constant in the pharma industry, but it doesn't have to be painful. Discover how suppliers can help ease the burden of regulatory change management and streamline essential processes.
-
Straight From The Source: A Live Q&A With The Inventors Of KinetiSol™5/22/2026
Experts discuss a solvent-free fusion process for amorphous solid dispersions, highlighting formulation flexibility, scale-up, process control, and early strategies to reduce risk and support commercialization.
-
Late‑Stage Progress In Excipients For Precision Nanomedicine5/6/2026
View late‑stage development and GMP manufacturing of novel excipients for nanomedicines, emphasizing regulatory rigor, process optimization, analytics, and scale‑up for lipid‑based delivery systems.
-
Designing An Inspector Rotation That Holds Up8/3/2026
Establish robust visual inspection rotations by separating planned dates from compliance expirations and using standardized templates to prevent scheduling bottlenecks.
-
A CDMO's Take On Psychedelic Formulation1/26/2026
Psychedelics show therapeutic promise, but face major formulation and regulatory hurdles. Advances in delivery and neuroscience may unlock new mental‑health treatments.
-
Pharmaceutical Requirements For Portable Monitoring In Cleanrooms3/5/2026
Maintain rigorous pharmaceutical cleanroom standards through strategic environmental monitoring. Explore essential guidelines for particle detection and effective data analysis to ensure compliance.
QUALITY CONTROL SOLUTIONS
-
![tablet-conveyor-GettyImages-1355719195]( "Comprehensive Batch And Lot Testing Services")
Batch and lot testing for release are critical steps in ensuring the quality and consistency of pharmaceutical tablets. Natoli Scientific provides comprehensive batch testing services that align with stringent industry standards and regulatory requirements. Each lot undergoes a rigorous analysis to verify that it meets predefined specifications for weight, tablet breaking force, thickness, diameter, and dissolution, among other critical quality attributes. The testing process is meticulously designed to screen for any variation that could impact the efficacy or safety of the final product.
Utilizing state-of-the-art analytical equipment and methodologies, our experts ensure that each batch released by our clients is of the highest quality, providing end-users with the assurance that the medications they rely on are both safe and effective. This level of attention to detail fosters trust and reliability in pharmaceutical products processed through Natoli Scientific’s advanced batch and lot testing services.
-
![Pharma Manufacturing 450x300]( "Continuous Monitoring Of Cleanrooms And Isolators")
FMS/BioTrak/Portable/Remote/Environmental Sensors
-
![PO 3 - GCApp_Stereo Microscope (person with blue coat)]( "Minimizing Uncertainty Throughout The Development Lifecycle")
Wearable technologies that allow for dosing of high-volume biologics over a longer time need to be designed with manufacturability end-user needs in mind and must comply with the highest quality and regulatory standards.
-
![GettyImages-2178790629 cell]( "Cell & Gene Therapies: Automating the Future of Regenerative Medicine")
Scaling cell and gene therapies requires transitioning manual workflows to automated, closed environments. Modular platforms optimize cleanroom footprint, accelerate production, and ensure consistent batch quality through real-time monitoring and seamless digital traceability.
-
![GettyImages-2174865773 vial testing, lab]( "Advancing Nitrosamine Testing For Evolving Regulations")
Explore how specialized analytical expertise and advanced instrumentation enable precise nitrosamine testing to help drug developers meet strict and evolving regulatory requirements.
